A diagnosis of idiopathic hypereosinophilic syndrome was made in a 68-year-old woman in 2002. A diagnostic work-up including radiological evaluation failed to reveal an overt lymphoproliferative disorder. Currently, 6 months after the revised diagnosis, the patient is well with an eosinophil count of 0.3 · 109/l on alemtuzumab (30 mg) every 3 weeks.

Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report

PITINI, Vincenzo;TETI, Diana;ARRIGO, Carmela;RIGHI, Maria
2004-01-01

Abstract

A diagnosis of idiopathic hypereosinophilic syndrome was made in a 68-year-old woman in 2002. A diagnostic work-up including radiological evaluation failed to reveal an overt lymphoproliferative disorder. Currently, 6 months after the revised diagnosis, the patient is well with an eosinophil count of 0.3 · 109/l on alemtuzumab (30 mg) every 3 weeks.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/1703770
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 76
  • ???jsp.display-item.citation.isi??? ND
social impact